(Q39979957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

7

Ilan Bruchim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Walter H Gotlieb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Marie-Claude Beauchamp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jing Gu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Susie Lau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Michael N Pollak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

21 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

246-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18495226%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Chronic activation of AMP-activated kinase as a strategy for slowing aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

TOR signaling in growth and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Signaling control of mRNA translation in cancer pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Role of AMP-activated protein kinase in mechanism of metformin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Metformin and reduced risk of cancer in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Compound C inhibits hypoxic activation of HIF-1 independent of AMPK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Insulin-like growth factor-related signaling and cancer development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

The Akt-mTOR tango and its relevance to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

The inhibition of the transplacental blastomogenic effect of nitrosomethylurea by postnatal administration of buformin to rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008

Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.008